SynthesisThe oncologist2025

De-escalating first-line treatment in stage IVB or recurrent cervical cancer: outcomes of immunotherapy alone and systemic review.

Akram Saad et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.